AIMT.US
id: 1384
Aimmune Therapeutics (AIMT) Investor Settlement
The parties have reached an agreement to settle the case, but the terms are still being finalized.
N.D. California
Court3:20-cv-06733
Case number08/31/2020
Class period Start09/25/2020
Class period EndAimmune Therapeutics reached a settlement with $AIMT investors over claims that it misled them on financial details and the fairness of its merger with Nestlé.
Case Status
Tentative Settlement
Alleged Offence
Misleading Statements,
Financial Misrepresentation,
Failure to Disclose,
Breach of Fiduciary duty
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Filing date
08/31/2020
Lead Plaintiff Deadline
09/25/2020
Plaintiffs
Steven Germano; Cecilia Pemberton; Bruce Svitak; Barbara C. Svitak
Attorneys
Kahn Swick & Foti, LLC; Monteverde & Associates PC
Judge
James Donato
Trades matching type
FIFO